Amicus Therapeutics SG&A Expense (Annual) Insights

Amicus Therapeutics Inc (FOLD)

9.955 +0.14 (+1.48%) USD | NASDAQ | Jul 05, 15:05

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2005. Upgrade now.

Date	Value
December 31, 2023	275.27M
December 31, 2022	213.04M
December 31, 2021	192.71M
December 31, 2020	156.41M
December 31, 2019	169.86M
December 31, 2018	127.20M
December 31, 2017	88.67M
December 31, 2016	71.15M
December 31, 2015	47.27M
December 31, 2014	20.72M

Date	Value
December 31, 2013	18.89M
December 31, 2012	19.36M
December 31, 2011	19.88M
December 31, 2010	15.66M
December 31, 2009	19.97M
December 31, 2008	19.67M
December 31, 2007	15.28M
December 31, 2006	12.28M
December 31, 2005	6.877M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

156.41M

Minimum

2020

275.27M

Maximum

2023

201.46M

Average

192.71M

Median

2021

SG&A Expense (Annual) Benchmarks